
Julia Belk
Immunologist and HHMI Hanna Gray Fellow (Stanford Medicine) whose Nature study showed blood-derived immune cells replace brain microglia during aging.
3
APPEARANCES
3
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
OCT 19
OCT 26
NOV 2
Oct 23, 2026
What an immune invasion teaches us about Alzheimer’s disease | Julia Belk
10:39
10:52
11:05
33:32

Julia BelkGUEST
And in particular, what caught my eye is they can really be curative in certain cases.

Julia BelkGUEST
And it's also a really exciting time because we've just had this explosion of technologies to actually measure the immune system and human cells more broadly with incredible resolution at incredible scale.

Julia BelkGUEST
So for me, coming as someone with a more quantitative background, I felt it was really perfect timing where my skill set was actually useful and some of the problems were really, really compelling.
22 MINS LATER

Nicholas WeilerHOST
Why do you think those mutant cells, which are generally bad for our health, heart disease, metabolic syndrome, cancer, why might those mutations be protective against Alzheimer's?
Your Aging Brain Gets Help From Your Blood. A New Hope for Alzheimer’s? | Dr. Julia Belk, PhD #85
33:50
34:09
35:48

Julia BelkGUEST
So there are already some, um, or, or one approved therapy that actually is curative in a, in a brain disorder l- uh, by, by using a bone marrow transplant, um, in part to replace defective microglia.

Julia BelkGUEST
So this, this disorder is a rare genetic disease called cerebral adrenoleukodystrophy, cerebral X-linked adrenoleukodystrophy, that's caused by a mutation in a gene on the X chromosome.

Josh HelmanHOST
And, and in, in terms of delivering this new therapy, it's, it's a surgical procedure in humans, it sounds like? Or-
Two Landmark Studies Challenge Dogma About our Brain Immune Cells and Aging
6:52
7:04
7:13
7:21
17:16

Julia BelkGUEST
And similar to Nathan, I'm super excited that these two completely different approaches from our two teams really converged on the exact same human biology almost at the same time.

Julia BelkGUEST
And so exactly like you set up, we set out to study mutations and use mutations as a lineage tracing approach.

Julia BelkGUEST
And the way we really got into this was actually several years ago, looking at people with this phenomenon called clonal hematopoiesis.

Julia BelkGUEST
And what clonal hematopoiesis is, is these precancerous mutations that are present in the blood.
10 MINS LATER
Eric TopolHOST
And Julia, is this only something that happens in humans and not in primates and other species?